• DOI:10.1097/00007611-199601000-00005
Corpus ID: 12798818

Drug Therapy in Attention-Deficit Hyperactivity Disorder

@article{Kessler1996DrugTI,
  title={Drug Therapy in Attention-Deficit Hyperactivity Disorder},
  author={S. Kessler},
  journal={Southern Medical Journal},
  year={1996},
  volume={89},
  pages={33-38}
}

• S. Kessler
• Published 1996
• Medicine
• Southern Medical Journal

Of 292 patients (210 males and 82 females) receiving medication for attentiondeficit hyperactivity disorder (ADHD), 272 (93%) responded well to sustained-release dextroamphetamine (D-Amp) and 21 patients (7%) to sustained-release methylphenidate (MPD). The dose of D-Amp ranged from 0.2 to 3.6 mg/kg/day and the dose of MPD from 1.4 to 7.7 mg/kg/day, without side effects requiring cessation of therapy. This suggests that the clinical improvement rate can be increased to nearly 100% in appropriate… Expand

View on Wolters Kluwer

ncbi.nlm.nih.gov

Save to Library

Create Alert

Cite

Launch Research Feed